Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy
Authors:
- Alessandro De LucaALAlessandro De Luca
- Jessica N. McAlpineJMJessica N. McAlpine
- Y.Z. WangY.Z. Wang
- 1 August 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 110 (2) , 256-264
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesBMC Cancer, 2008
- Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial CancerClinical Cancer Research, 2005
- Targeting the DNA repair defect of BRCA tumoursCurrent Opinion in Pharmacology, 2005
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with ImmunomodulationThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated DailyJournal of Clinical Oncology, 2002
- Cancer Incidence in a Population of Jewish Women at Risk of Ovarian CancerJournal of Clinical Oncology, 2002
- Morphological effects of chemotherapy on ovarian carcinomaJournal of Clinical Pathology, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001